US Patent 9579365 Therapeutic ribonucleases
Patent 9579365 was granted and assigned to Quintessence Biosciences on February, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 14, 2015
Date of Patent
February 28, 2017
Patent Applicant
Patent Application Number
14686410
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9579365 Therapeutic ribonucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.